Nanocomposites (Dec 2022)

In-situ synthesis of reduced graphene oxide/silver nanoparticles (rGO/AgNPs) nanocomposites for high loading capacity of acetylsalicylic acid

  • Murni Handayani,
  • Bagus Indra Suwaji,
  • Geolita Ihsantia Ning Asih,
  • Triana Kusumaningsih,
  • Yuni Kusumastuti,
  • Rochmadi,
  • Isa Anshori

DOI
https://doi.org/10.1080/20550324.2022.2054210
Journal volume & issue
Vol. 8, no. 1
pp. 74 – 80

Abstract

Read online

Graphene has excellent properties which can be a promising material as nanocomposites for application in a drug delivery system (DDS). In this study, reduced graphene oxide/silver nanoparticles (rGO/AgNPs) nanocomposites was synthesized using a facile in-situ method for drug loading application of acetylsalicylic acid (ASA). The synthesis results were characterized by FESEM, EDX, UV-Vis, XRD, and Raman spectrophotometers analyses. The results showed that rGO/AgNPs nanocomposites was synthesized successfully. Drug loading application was performed using UV-Vis measurements. The loading results depicted that rGO/AgNPs is successfully created in high-capacity loading for ASA. Drug loading performances enhanced with the increasing loading time of ASA on rGO/AgNPs. The optimum percentage of drug loading capacity for ASA by rGO/AgNPs was ∼83% in a contact time of 30 hrs.

Keywords